Compare PPSI & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPSI | BCTX |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1M | 26.6M |
| IPO Year | 2008 | 2025 |
| Metric | PPSI | BCTX |
|---|---|---|
| Price | $2.96 | $3.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $40.00 |
| AVG Volume (30 Days) | 56.9K | ★ 85.3K |
| Earning Date | 04-08-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,627,000.00 | N/A |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | $22.42 | $380.95 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.75 | N/A |
| 52 Week Low | $2.35 | $0.63 |
| 52 Week High | $6.29 | $14.68 |
| Indicator | PPSI | BCTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.46 | 46.99 |
| Support Level | $2.75 | $3.27 |
| Resistance Level | $3.36 | $3.74 |
| Average True Range (ATR) | 0.23 | 0.23 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 26.00 | 25.00 |
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets. The Company launched two new product platforms namely, PRYMUS, a new, mobile on-site power system concentrating on customers with requirements of 1-10 megawatts of mobile power and PowerCore, a residential and small commercial based primary generator system integrating a DC fast charger into one solution.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.